1637P Efficacy of Talazoparib and Enzalutamide in Mcrpc Patients Previously Treated with Androgen Receptor Pathway Inhibitors (ARPI) or Docetaxel: Post Hoc Analysis from Both Cohorts in TALAPRO-2 Study
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined